What is the address of Dr Raptis Alexandros, Diagnostic Pathology?

The registered office of Dr Raptis Alexandros, Diagnostic Pathology is located at Rue des Marcottes 24, 7000 Mons.

Is Dr Raptis Alexandros, Diagnostic Pathology still active?

Yes. According to the CBE (1 October 2026) Dr Raptis Alexandros, Diagnostic Pathology is active, legal situation “Normale toestand”, started on 19 August 2020.

Is Dr Raptis Alexandros, Diagnostic Pathology registered on Peppol?

Yes, Dr Raptis Alexandros, Diagnostic Pathology is registered on the Peppol network with ID 0208:0752752068.

What is the enterprise number of Dr Raptis Alexandros, Diagnostic Pathology?

The enterprise number of Dr Raptis Alexandros, Diagnostic Pathology is BE0752752068.

When was Dr Raptis Alexandros, Diagnostic Pathology founded?

Dr Raptis Alexandros, Diagnostic Pathology was founded on 19 August 2020.

Is Dr Raptis Alexandros, Diagnostic Pathology a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 August 2020; 5 annual accounts filed, latest fiscal year 2025.

How much profit did Dr Raptis Alexandros, Diagnostic Pathology make in 2025?

Dr Raptis Alexandros, Diagnostic Pathology posted a profit after taxes of € 286,399 in financial year 2025.

What is the revenue of Dr Raptis Alexandros, Diagnostic Pathology?

As a small company, Dr Raptis Alexandros, Diagnostic Pathology is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 371,497.

Dr Raptis Alexandros, Diagnostic Pathology (Private Limited)

Dossier Dr Raptis Alexandros, Diagnostic Pathology, printed on 1 October 2026 from databakkes.be/en/0752752068/dr-raptis-alexandros-diagnostic-pathology. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2023.

Financials

Financial year 2025

Dr Raptis Alexandros, Diagnostic Pathology from Mons, company number BE0752752068, closed financial year 2025 with a result of € 286,399 after tax. For that financial year Dr Raptis Alexandros, Diagnostic Pathology recorded a gross margin of € 371,497 and equity of € 167,347. Compared with financial year 2024, the result moved from € 249,599 to € 286,399. Profitable, and profit is growing. The buffer shrank hard: equity is 52 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.

What it is worth Shrank hard

€ 167,347

▼ 52% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 286,399

▲ 15% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 359,426

▲ 25% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 466,200 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 8,846

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,626

▼ 41% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 11,516

▲ 29% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 237,551 Gross margin 2022: € 237,551 First fiscal year in the series	€ 298,758 Gross margin 2023: € 298,758 ▲ 26% vs 2022 (€ 237,551) Favourable step	€ 328,156 Gross margin 2024: € 328,156 ▲ 10% vs 2023 (€ 298,758) Favourable step	€ 371,497 Gross margin 2025: € 371,497 ▲ 13% vs 2024 (€ 328,156) Favourable step	▲ 13%
Profit after taxes	€ 158,948 Profit after taxes 2022: € 158,948 First fiscal year in the series	€ 221,101 Profit after taxes 2023: € 221,101 ▲ 39% vs 2022 (€ 158,948) Favourable step	€ 249,599 Profit after taxes 2024: € 249,599 ▲ 13% vs 2023 (€ 221,101) Favourable step	€ 286,399 Profit after taxes 2025: € 286,399 ▲ 15% vs 2024 (€ 249,599) Favourable step	▲ 15%
Equity	€ 297,549 Equity 2022: € 297,549 First fiscal year in the series	€ 297,549 Equity 2023: € 297,549 Unchanged (€ 297,549) Unchanged	€ 347,148 Equity 2024: € 347,148 ▲ 17% vs 2023 (€ 297,549) Favourable step	€ 167,347 Equity 2025: € 167,347 ▼ 52% vs 2024 (€ 347,148) Unfavourable step	▼ 52%
Total debts	€ 83,765 Total debts 2022: € 83,765 First fiscal year in the series	€ 530,908 Total debts 2023: € 530,908 ▲ € 447,143 vs 2022 (€ 83,765) Unfavourable step	€ 351,142 Total debts 2024: € 351,142 ▼ 34% vs 2023 (€ 530,908) Favourable step	€ 622,353 Total debts 2025: € 622,353 ▲ 77% vs 2024 (€ 351,142) Unfavourable step	▲ 77%
Cash	€ 259,555 Cash 2022: € 259,555 First fiscal year in the series	€ 411,405 Cash 2023: € 411,405 ▲ 59% vs 2022 (€ 259,555) Favourable step	€ 288,249 Cash 2024: € 288,249 ▼ 30% vs 2023 (€ 411,405) Unfavourable step	€ 359,426 Cash 2025: € 359,426 ▲ 25% vs 2024 (€ 288,249) Favourable step	▲ 25%
Retained profit	€ 289,549 Retained profit 2022: € 289,549 First fiscal year in the series	€ 289,549 Retained profit 2023: € 289,549 Unchanged (€ 289,549) Unchanged	€ 339,148 Retained profit 2024: € 339,148 ▲ 17% vs 2023 (€ 289,549) Favourable step	€ 159,347 Retained profit 2025: € 159,347 ▼ 53% vs 2024 (€ 339,148) Unfavourable step	▼ 53%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 221,101 Dividend 2023: € 221,101 Unchanged (€ 0) Unchanged	€ 200,000 Dividend 2024: € 200,000 ▼ 10% vs 2023 (€ 221,101) Unchanged	€ 466,200 Dividend 2025: € 466,200 ▲ 133% vs 2024 (€ 200,000) Unchanged	▲ 133%
Bank debt	€ 6,187 Bank debt 2022: € 6,187 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 6,187) Favourable step	€ 23,702 Bank debt 2024: € 23,702 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 23,702) Favourable step	▼ 100%
Balance sheet total	€ 381,314 Balance sheet total 2022: € 381,314 First fiscal year in the series	€ 828,457 Balance sheet total 2023: € 828,457 ▲ 117% vs 2022 (€ 381,314) Unchanged	€ 698,290 Balance sheet total 2024: € 698,290 ▼ 16% vs 2023 (€ 828,457) Unchanged	€ 789,700 Balance sheet total 2025: € 789,700 ▲ 13% vs 2024 (€ 698,290) Unchanged	▲ 13%

Key figures of Dr Raptis Alexandros, Diagnostic Pathology, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr Raptis Alexandros, Diagnostic Pathology?

What happened at Dr Raptis Alexandros, Diagnostic Pathology in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 27, 2026 New annual accounts for financial year 2025: profit of € 286,399 (▲ 15% vs 2024). Source: NBB ↗
Aug 19, 2020 New establishment in Tournai. KBO
Aug 19, 2020 Start of the company according to the CBE. KBO

In short

From € 158,948 profit in 2022 to € 286,399 profit in 2025.

Paid € 309,424 in corporate taxes since 2022.

Best year ever: 2025, with € 286,399 profit.

Paid out € 887,302 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr Raptis Alexandros, Diagnostic Pathology? We notify you, reason included.

Follow Dr Raptis Alexandros, Diagnostic Pathology

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Marcottes 24

7000 Mons

2.306.113.335

Rue des Sports(TOU) 51

7500 Tournai

Active since 19 August 2020

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0752.752.068
VAT number: BE 0752.752.068
Registered office: Rue des Marcottes 24, 7000 Mons
Names & denominations: Dr Raptis Alexandros, Diagnostic Pathology
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 19 August 2020
Peppol: Active · Active since 13 Oct 2025

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr Raptis Alexandros, Diagnostic Pathology